For instance, MYCN directly induces the transcription of SIRT1 (class III HDACs), and pharmacological inhibition via cambinol (a SIRT1 inhibitor) effectively reduces the growth of tumors in an MYCN‐driven transgenic mouse model of NB.251. Here, MYCN is linked to neuroblastoma.